Biotech · Private company
LumaBridge
Track this companyFree. Adds LumaBridge to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Autologous TLPO Vaccine BasketPHASE2 · TERMINATED · started Nov 29, 2023ClinicalTrials.gov NCT06175221 · fetched Nov 12, 2026
- Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersPHASE1_PHASE2 · COMPLETED · started Sep 30, 2019ClinicalTrials.gov NCT03761914 · fetched Nov 12, 2026
- Combination Study of SV-BR-1-GM With RetifanlimabPHASE1_PHASE2 · COMPLETED · started Mar 16, 2018ClinicalTrials.gov NCT03328026 · fetched Nov 12, 2026
- Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.PHASE1_PHASE2 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02678741 · fetched Nov 12, 2026
- Phase IIB TL + YCWP + DC in MelanomaPHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02301611 · fetched Nov 12, 2026